Aidapak Recalls Aspirin Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling 325 mg aspirin tablets because they may have been mislabeled as other prescription medications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' severity score under the rubric, particularly given the risk of patients taking incorrect prescription medications.
Plain-English summary
Aidapak Services, LLC is recalling 900-tablet bottles of 325 mg aspirin tablets (NDC 00536330501) due to a labeling error. The recall is classified as FDA Class II.
The source text indicates that the aspirin tablets may have been mislabeled as other drugs, including pancrelipase, acetazolamide, metoprolol tartrate, and rivaroxaban. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. Specific pedigree codes and expiration dates are listed in the recall notice.
Consumers should check their medication labels and stop using the product if it matches the recalled description. They should contact their healthcare provider or pharmacist for guidance on appropriate medication.
The recalled product
- Product
- ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536330501.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 900
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- ASPIRIN
- Tablet
- 325 mg has the following codes: Pedigree: W003355
- EXP: 6/19/2014
- Pedigree: W003525
- EXP: 6/21/2014
- Pedigree: W002573
- EXP: 6/3/2014
- Pedigree: W002624
- EXP: 6/4/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAspirin Tablets Recalled for Potential Mislabeling as Cholecalciferol
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Mislabelled Ibuprofen Tablets Distributed by Aidapak Services
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Acetaminophen Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Aspirin EC Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighAripiprazole Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Caffeine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22